delete Therapeutic Goods (Charges) Amendment Regulations 2003 (No. 1)
Amendment to the Therapeutic Goods (Charges) regulations 2003, likely adjusting fees for services provided by the Therapeutic Goods Administration such as product registration, assessment, and licensing.
The charges impose unnecessary compliance costs on businesses that are ultimately passed to consumers, reducing access to essential health products. They distort market incentives, create barriers to entry for smaller firms, and add to the regulatory burden without clear evidence of additional public benefit. Funding for the TGA could be obtained through less economically damaging means.